 |
BioWorld-International-2002-01-09
PPL Clones Knockout Pigs, Says Dolly’s Arthritis Not A Setback
ExonHit Partners With IDEC To Develop Antibody Therapeutics
PARIS - ExonHit Therapeutics SA and IDEC Pharmaceuticals Corp. signed a collaboration and research agreement aimed at discovering new antigen targets for antibody therapy, with a particular focus on prostate carcinoma.